ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PARP Inhibitor Biomarkers Service Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-18V5872
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global PARP Inhibitor Biomarkers Service Market Insights and Forecast to 2028
BUY CHAPTERS

Global PARP Inhibitor Biomarkers Service Market Research Report 2025

Code: QYRE-Auto-18V5872
Report
September 2025
Pages:60
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Myriad Genetics Inc
Hoffmann-La Roche AG
Invitae Corporation
NeoGenomics Laboratories Inc.
BPS Bioscience, Inc.

PARP Inhibitor Biomarkers Service Market

The global market for PARP Inhibitor Biomarkers Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for PARP Inhibitor Biomarkers Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for PARP Inhibitor Biomarkers Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for PARP Inhibitor Biomarkers Service in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of PARP Inhibitor Biomarkers Service include Myriad Genetics, Inc., Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc., BPS Bioscience, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PARP Inhibitor Biomarkers Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PARP Inhibitor Biomarkers Service.
The PARP Inhibitor Biomarkers Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PARP Inhibitor Biomarkers Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PARP Inhibitor Biomarkers Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of PARP Inhibitor Biomarkers Service Market Report

Report Metric Details
Report Name PARP Inhibitor Biomarkers Service Market
Segment by Type
  • BRCA 1 & 2 Testing
  • HRD Testing
  • HRR Testing
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Myriad Genetics, Inc., Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc., BPS Bioscience, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of PARP Inhibitor Biomarkers Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the PARP Inhibitor Biomarkers Service Market report?

Ans: The main players in the PARP Inhibitor Biomarkers Service Market are Myriad Genetics, Inc., Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc., BPS Bioscience, Inc.

What are the Application segmentation covered in the PARP Inhibitor Biomarkers Service Market report?

Ans: The Applications covered in the PARP Inhibitor Biomarkers Service Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the PARP Inhibitor Biomarkers Service Market report?

Ans: The Types covered in the PARP Inhibitor Biomarkers Service Market report are BRCA 1 & 2 Testing, HRD Testing, HRR Testing, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 BRCA 1 & 2 Testing
1.2.3 HRD Testing
1.2.4 HRR Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global PARP Inhibitor Biomarkers Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global PARP Inhibitor Biomarkers Service Market Perspective (2020-2031)
2.2 Global PARP Inhibitor Biomarkers Service Growth Trends by Region
2.2.1 Global PARP Inhibitor Biomarkers Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 PARP Inhibitor Biomarkers Service Historic Market Size by Region (2020-2025)
2.2.3 PARP Inhibitor Biomarkers Service Forecasted Market Size by Region (2026-2031)
2.3 PARP Inhibitor Biomarkers Service Market Dynamics
2.3.1 PARP Inhibitor Biomarkers Service Industry Trends
2.3.2 PARP Inhibitor Biomarkers Service Market Drivers
2.3.3 PARP Inhibitor Biomarkers Service Market Challenges
2.3.4 PARP Inhibitor Biomarkers Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PARP Inhibitor Biomarkers Service Players by Revenue
3.1.1 Global Top PARP Inhibitor Biomarkers Service Players by Revenue (2020-2025)
3.1.2 Global PARP Inhibitor Biomarkers Service Revenue Market Share by Players (2020-2025)
3.2 Global PARP Inhibitor Biomarkers Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by PARP Inhibitor Biomarkers Service Revenue
3.4 Global PARP Inhibitor Biomarkers Service Market Concentration Ratio
3.4.1 Global PARP Inhibitor Biomarkers Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PARP Inhibitor Biomarkers Service Revenue in 2024
3.5 Global Key Players of PARP Inhibitor Biomarkers Service Head office and Area Served
3.6 Global Key Players of PARP Inhibitor Biomarkers Service, Product and Application
3.7 Global Key Players of PARP Inhibitor Biomarkers Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 PARP Inhibitor Biomarkers Service Breakdown Data by Type
4.1 Global PARP Inhibitor Biomarkers Service Historic Market Size by Type (2020-2025)
4.2 Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Type (2026-2031)
5 PARP Inhibitor Biomarkers Service Breakdown Data by Application
5.1 Global PARP Inhibitor Biomarkers Service Historic Market Size by Application (2020-2025)
5.2 Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America PARP Inhibitor Biomarkers Service Market Size (2020-2031)
6.2 North America PARP Inhibitor Biomarkers Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America PARP Inhibitor Biomarkers Service Market Size by Country (2020-2025)
6.4 North America PARP Inhibitor Biomarkers Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PARP Inhibitor Biomarkers Service Market Size (2020-2031)
7.2 Europe PARP Inhibitor Biomarkers Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe PARP Inhibitor Biomarkers Service Market Size by Country (2020-2025)
7.4 Europe PARP Inhibitor Biomarkers Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size (2020-2031)
8.2 Asia-Pacific PARP Inhibitor Biomarkers Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2020-2025)
8.4 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PARP Inhibitor Biomarkers Service Market Size (2020-2031)
9.2 Latin America PARP Inhibitor Biomarkers Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2020-2025)
9.4 Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size (2020-2031)
10.2 Middle East & Africa PARP Inhibitor Biomarkers Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Country (2020-2025)
10.4 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Myriad Genetics, Inc.
11.1.1 Myriad Genetics, Inc. Company Details
11.1.2 Myriad Genetics, Inc. Business Overview
11.1.3 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Introduction
11.1.4 Myriad Genetics, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2020-2025)
11.1.5 Myriad Genetics, Inc. Recent Development
11.2 Hoffmann-La Roche AG
11.2.1 Hoffmann-La Roche AG Company Details
11.2.2 Hoffmann-La Roche AG Business Overview
11.2.3 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Introduction
11.2.4 Hoffmann-La Roche AG Revenue in PARP Inhibitor Biomarkers Service Business (2020-2025)
11.2.5 Hoffmann-La Roche AG Recent Development
11.3 Invitae Corporation
11.3.1 Invitae Corporation Company Details
11.3.2 Invitae Corporation Business Overview
11.3.3 Invitae Corporation PARP Inhibitor Biomarkers Service Introduction
11.3.4 Invitae Corporation Revenue in PARP Inhibitor Biomarkers Service Business (2020-2025)
11.3.5 Invitae Corporation Recent Development
11.4 NeoGenomics Laboratories, Inc.
11.4.1 NeoGenomics Laboratories, Inc. Company Details
11.4.2 NeoGenomics Laboratories, Inc. Business Overview
11.4.3 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Introduction
11.4.4 NeoGenomics Laboratories, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2020-2025)
11.4.5 NeoGenomics Laboratories, Inc. Recent Development
11.5 BPS Bioscience, Inc.
11.5.1 BPS Bioscience, Inc. Company Details
11.5.2 BPS Bioscience, Inc. Business Overview
11.5.3 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Introduction
11.5.4 BPS Bioscience, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2020-2025)
11.5.5 BPS Bioscience, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Myriad Genetics Inc
Hoffmann-La Roche AG
Invitae Corporation
NeoGenomics Laboratories Inc.
BPS Bioscience, Inc.
List of Tables
 Table 1. Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of BRCA 1 & 2 Testing
 Table 3. Key Players of HRD Testing
 Table 4. Key Players of HRR Testing
 Table 5. Key Players of Others
 Table 6. Global PARP Inhibitor Biomarkers Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global PARP Inhibitor Biomarkers Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global PARP Inhibitor Biomarkers Service Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global PARP Inhibitor Biomarkers Service Market Share by Region (2020-2025)
 Table 10. Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global PARP Inhibitor Biomarkers Service Market Share by Region (2026-2031)
 Table 12. PARP Inhibitor Biomarkers Service Market Trends
 Table 13. PARP Inhibitor Biomarkers Service Market Drivers
 Table 14. PARP Inhibitor Biomarkers Service Market Challenges
 Table 15. PARP Inhibitor Biomarkers Service Market Restraints
 Table 16. Global PARP Inhibitor Biomarkers Service Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global PARP Inhibitor Biomarkers Service Market Share by Players (2020-2025)
 Table 18. Global Top PARP Inhibitor Biomarkers Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP Inhibitor Biomarkers Service as of 2024)
 Table 19. Ranking of Global Top PARP Inhibitor Biomarkers Service Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by PARP Inhibitor Biomarkers Service Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of PARP Inhibitor Biomarkers Service, Headquarters and Area Served
 Table 22. Global Key Players of PARP Inhibitor Biomarkers Service, Product and Application
 Table 23. Global Key Players of PARP Inhibitor Biomarkers Service, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global PARP Inhibitor Biomarkers Service Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Type (2020-2025)
 Table 27. Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Type (2026-2031)
 Table 29. Global PARP Inhibitor Biomarkers Service Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Application (2020-2025)
 Table 31. Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Application (2026-2031)
 Table 33. North America PARP Inhibitor Biomarkers Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America PARP Inhibitor Biomarkers Service Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America PARP Inhibitor Biomarkers Service Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe PARP Inhibitor Biomarkers Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe PARP Inhibitor Biomarkers Service Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe PARP Inhibitor Biomarkers Service Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific PARP Inhibitor Biomarkers Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America PARP Inhibitor Biomarkers Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa PARP Inhibitor Biomarkers Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Myriad Genetics, Inc. Company Details
 Table 49. Myriad Genetics, Inc. Business Overview
 Table 50. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Product
 Table 51. Myriad Genetics, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2020-2025) & (US$ Million)
 Table 52. Myriad Genetics, Inc. Recent Development
 Table 53. Hoffmann-La Roche AG Company Details
 Table 54. Hoffmann-La Roche AG Business Overview
 Table 55. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Product
 Table 56. Hoffmann-La Roche AG Revenue in PARP Inhibitor Biomarkers Service Business (2020-2025) & (US$ Million)
 Table 57. Hoffmann-La Roche AG Recent Development
 Table 58. Invitae Corporation Company Details
 Table 59. Invitae Corporation Business Overview
 Table 60. Invitae Corporation PARP Inhibitor Biomarkers Service Product
 Table 61. Invitae Corporation Revenue in PARP Inhibitor Biomarkers Service Business (2020-2025) & (US$ Million)
 Table 62. Invitae Corporation Recent Development
 Table 63. NeoGenomics Laboratories, Inc. Company Details
 Table 64. NeoGenomics Laboratories, Inc. Business Overview
 Table 65. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Product
 Table 66. NeoGenomics Laboratories, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2020-2025) & (US$ Million)
 Table 67. NeoGenomics Laboratories, Inc. Recent Development
 Table 68. BPS Bioscience, Inc. Company Details
 Table 69. BPS Bioscience, Inc. Business Overview
 Table 70. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Product
 Table 71. BPS Bioscience, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2020-2025) & (US$ Million)
 Table 72. BPS Bioscience, Inc. Recent Development
 Table 73. Research Programs/Design for This Report
 Table 74. Key Data Information from Secondary Sources
 Table 75. Key Data Information from Primary Sources
 Table 76. Authors List of This Report


List of Figures
 Figure 1. PARP Inhibitor Biomarkers Service Picture
 Figure 2. Global PARP Inhibitor Biomarkers Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global PARP Inhibitor Biomarkers Service Market Share by Type: 2024 VS 2031
 Figure 4. BRCA 1 & 2 Testing Features
 Figure 5. HRD Testing Features
 Figure 6. HRR Testing Features
 Figure 7. Others Features
 Figure 8. Global PARP Inhibitor Biomarkers Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global PARP Inhibitor Biomarkers Service Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Clinic Case Studies
 Figure 12. Others Case Studies
 Figure 13. PARP Inhibitor Biomarkers Service Report Years Considered
 Figure 14. Global PARP Inhibitor Biomarkers Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global PARP Inhibitor Biomarkers Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global PARP Inhibitor Biomarkers Service Market Share by Region: 2024 VS 2031
 Figure 17. Global PARP Inhibitor Biomarkers Service Market Share by Players in 2024
 Figure 18. Global Top PARP Inhibitor Biomarkers Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP Inhibitor Biomarkers Service as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by PARP Inhibitor Biomarkers Service Revenue in 2024
 Figure 20. North America PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America PARP Inhibitor Biomarkers Service Market Share by Country (2020-2031)
 Figure 22. United States PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe PARP Inhibitor Biomarkers Service Market Share by Country (2020-2031)
 Figure 26. Germany PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific PARP Inhibitor Biomarkers Service Market Share by Region (2020-2031)
 Figure 34. China PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America PARP Inhibitor Biomarkers Service Market Share by Country (2020-2031)
 Figure 42. Mexico PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa PARP Inhibitor Biomarkers Service Market Share by Country (2020-2031)
 Figure 46. Turkey PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE PARP Inhibitor Biomarkers Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Myriad Genetics, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2020-2025)
 Figure 50. Hoffmann-La Roche AG Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2020-2025)
 Figure 51. Invitae Corporation Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2020-2025)
 Figure 52. NeoGenomics Laboratories, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2020-2025)
 Figure 53. BPS Bioscience, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2020-2025)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global PARP Inhibitor Biomarkers Testing Product Market Research Report 2024
Global Poly ADP Ribose Polymerase PARP Inhibitors Market Research Report 2024
Global PARP Inhibitors for Breast Cancer Market Research Report 2024
DNA Repair PARP Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PARP1 Antibody Market Research Report 2024
Global Enzyme Poly ADP Ribose Polymerase PARP Inhibitor Market Insights Forecast to 2030
Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Insights Forecast to 2030
Global PORCN Inhibitor Market Research Report 2024
Global Genomic Biomarkers Market Research Report 2024
Global PARP Poly ADP ribose Polymerase Inhibitors Market Insights Forecast to 2030
Prostate Cancer PARP Inhibitor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Imaging Biomarker Market Research Report 2025
Global Tumor Biomarker Test Market Research Report 2024
Global FAP Inhibitor Market Research Report 2024
Cancer Growth Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global RNase Inhibitor Market Research Report 2025
Global Thrombin Inhibitor Market Research Report 2024
Global Biomarker POCT Market Research Report 2024
EGFR Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Predisposition Biomarkers Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions